You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
创新速递
公司新闻 创新速递 媒体报道
TaurusNXT®“非醛交联”干瓣TAVR系统完成多中心注册临床全部患者入组
2024-03-01 09:53:57

2024年2月,TaurusNXT®“非醛交联” 干瓣TAVR系统的多中心注册临床完成全部 患者入组。TaurusNXT®乃公司针对瓣膜耐久性难题,自研的第三代TAVR系统。其设计与TaurusOne®及TaurusElite®有明显不同,TaurusNXT®独特应用非醛生物组织交联技术进行瓣叶处理,从根源上消除了瓣膜钙化的诱因,从而解决人工瓣膜衰败的难题。


Top